Dr. Abigail A***

SGLT2 Inhibitor Mechanisms of Organ Protection Dialysis Modalities and Cardiovascular Mortality Type 2 Diabetes Insulin Resistance Mechanisms Cardiovascular Hemodynamics and Echocardiography Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) Lipoprotein Metabolism and PCSK9 Therapeutics Vascular Smooth Muscle Cell Phenotypic Switching Chronic Kidney Disease and Renal Fibrosis Diabetic Nephropathy Progression Biomarkers Adipose Tissue Inflammation and Thermogenesis Incretin Hormone Therapies (GLP-1/GIP Agonists) Kidney Transplantation and Allograft Rejection Sex- and Gender-Specific Health Disparities Digital Health Interventions and Telemedicine Patient-Reported Outcome Measures (PROMs)